Funding for this research was provided by:
National Institutes of Health (P30GM118228, DK113800)
University of Vermont Medical Center
MIT Center for Microbiome Informatics and Therapeutics
Received: 18 August 2020
Accepted: 23 June 2021
First Online: 8 July 2021
: The study protocol was approved by the Medical Ethics Committee of the University of Vermont (Document Number CHRMS15-373). Written informed consents from voluntary subjects were obtained.
: No identifiable data is presented.
: EJA, ZK and MS are cofounders of OpenBiome and Finch Therapeutics. ZK, MS, RJE, EV are employees of Finch Therapeutics. JWC and PLM consult for Finch Therapeutics. WFW, RJE, EV are employees of OpenBiome. GMM has research funding from Takeda Pharmaceuticals and is on the Scientific Advisory Board of Dignify Therapeutics.